SuperworthZoetis market cap ZTS
Share price times shares outstanding: what the whole company sells for, since 2013.
- Today, Oct 23, 2026
- $33.5B
- Highest close in our data
- $115.5B
- Dec 2021
Zoetis is worth $33.5B at the close on Oct 23, 2026, at $81.03 a share.
That is down 48% over the last year and down 67% over five years.
Its highest close in our data was $115.5B in Dec 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $33.5B | $28.8B | $56.2B | −40% |
| 2025 | $55.6B | $52.3B | $77.3B | −25% |
| 2024 | $74.3B | $67.1B | $91.3B | −18% |
| 2023 | $90.6B | $68.8B | $90.6B | +33% |
| 2022 | $68.3B | $62.3B | $99.9B | −41% |
| 2021 | $115.5B | $69.2B | $115.5B | +47% |
| 2020 | $78.7B | $47.9B | $80.4B | +24% |
| 2019 | $63.5B | $40.6B | $63.5B | +56% |
| 2018 | $40.6B | $35.3B | $45.8B | +16% |
| 2017 | $35.1B | $25.8B | $35.2B | +33% |
| 2016 | $26.4B | $20.1B | $26.6B | +11% |
| 2015 | $23.9B | $21.2B | $25.1B | +8% |
| 2014 | $22.2B | $14.2B | $22.5B | +36% |
| 2013 | $16.3B | $14.6B | $16.9B | n/a |
Against its peers
Companies in Healthcare nearest Zoetis' size, closest first, today.
| Company | Market cap |
|---|---|
| ZTSZoetis | $33.5B |
| MTDMettler-Toledo International | $33.5B |
| CNCCentene | $34.7B |
| GEHCGE HealthCare Technologies | $32.3B |
| RMDResMed | $36.5B |
| RPRXRoyalty Pharma | $36.7B |
| BIIBBiogen | $37B |
| ALNYAlnylam Pharmaceuticals | $30B |
| DXCMDexCom | $29.4B |
| WSTWest Pharmaceutical Services | $27.6B |
| ILMNIllumina | $40.7B |
| Peer median | $34.1B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Zoetis
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.